HCA Healthcare Inc (HCA)
SottovalutatoFondamentale
81
Prezzo
$427.57
Capitalizzazione
$95.97B
Parte 1 · Quanto vale l'azienda
Panoramica
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Per questa società non c'è ancora una scheda redazionale
Concorrenti diretti
Con chi questa società si contende gli stessi clienti
Generato il 18 settembre 2026 con claude-haiku-4-5 — condiviso con tutti gli utenti
È il concorrente quotato più vicino a HCA: Tenet gestisce ospedali per acuti e una grande rete di centri di chirurgia ambulatoriale spesso nelle stesse città del Sud degli Stati Uniti, contendendosi gli stessi pazienti, gli stessi medici e gli stessi contratti con le assicurazioni private.
Gestisce ospedali per acuti e la maggiore rete statunitense di strutture per la salute mentale, sovrapponendosi agli ospedali di HCA in stati come Nevada, Texas e Florida per gli stessi ricoveri e le stesse convenzioni con i pagatori.
Catena ospedaliera a scopo di lucro concentrata in città medio-piccole del Sud e del Midwest: compete con HCA per i volumi degli ospedali di comunità e per l'acquisizione dei medici negli stati in cui entrambe sono presenti.
Gestisce una trentina di ospedali per acuti e circa 280 punti di cura in aree urbane di media dimensione fra Texas, Oklahoma, New Mexico, Kansas, Idaho e New Jersey, alcune delle quali si sovrappongono direttamente alle reti ospedaliere di HCA.
Uno dei maggiori sistemi ospedalieri non profit degli Stati Uniti, con strutture in Tennessee, Texas e Florida che attraggono gli stessi pazienti degli ospedali di HCA; il 10-K di HCA indica proprio questi enti esenti da imposte fra i propri concorrenti.
Sistema non profit di oltre 140 ospedali nato dalla fusione fra Dignity Health e CHI, in concorrenza con HCA per i volumi di ricoveri e prestazioni ambulatoriali in Texas, Colorado, Nevada e California.
Stato Patrimoniale e Liquidità
Ricavi
$76.39B
Ultimi 12 mesi (al 31/03/2026)
Utile Netto
$6.79B
Ultimi 12 mesi (al 31/03/2026)
Free Cash Flow
$7.69B
Patrimonio Netto Totale
$-6.03B
Passività Totali
$63.49B
Rapporto di Liquidità
0.83
Copertura Interessi
-
Debito/EBITDA
3.17
Utile per Azione
Ricavi e Utile Netto
Free Cash Flow
Scomposizione Ricavi
Prospetto storico
Margini nel tempo
Il debito nel tempo
Quanto pesa il debito
Griglia della crescita
Crescita — Ricavi
Stima del Fair Value
Fair Value
$685.77
Prezzo Attuale
$427.57
Margine di Sicurezza
+37.7%
Range Fair Value
$445.75 - $925.79
Intervallo di dispersione tra i metodi di valutazione usati, non una stima statisticamente calibrata.
Metodi di Stima
Metriche di Valutazione
Rapporto P/E
14.70
ROE
-112.6%
Rapporto P/B
-
P/FCF
11.94
Margine Lordo
-
ROIC
-
Radar Redditività
Creazione di Valore (Vantaggio Competitivo)
ROIC
-
WACC
8.3%
ROIC − WACC
-
Criteri di Analisi Fondamentale
Superati (18)
- EPS shows upward trend
- EPS CAGR 16.56%
- Price CAGR 19.15%
- P/FCF 11.94
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- Low reliance on intangibles
- ROE 695.7%
- Revenue Growth 5Y 8.0%
- Analyst Consensus 57% Buy
- Earnings Surprise avg 7.2%
- PEG Ratio 0.65
- Earnings Quality (OCF/NI) 1.91
- Share Dilution -8.5%
- Net Margin Trend 8.9% vs 8.1%
- Piotroski F-Score 6/9
Non superati (2)
- CapEx intensity
- DCF valuation (Overvalued)
Non disponibili (8)
- ROIC NaN%
- Gross Margin NaN%
- P/B Ratio NaN
- Dividend Payout NaN%
- Debt/Equity ratio
- Operating Margin NaN%
- Interest Coverage
- Price below Graham Number
Piotroski F-Score
Segnali misti: alcune aree necessitano attenzione
Qualità degli Utili
Alta qualità: utili supportati da cash
Diluizione Azionaria
Riacquisto azioni. Favorevole agli azionisti
Partecipazioni istituzionali
Governance
Team Dirigenziale
| Nome | Ruolo | Età |
|---|---|---|
| Mr. Samuel N. Hazen | CEO & Director | 65 |
| Mr. Michael A. Marks | CFO & Executive VP | 55 |
| Mr. Jon Mack Foster | Executive VP & COO | 63 |
| Mr. Michael R. McAlevey | Executive VP and Chief Legal & Administrative Officer | 61 |
| Dr. Michael S. Cuffe M.B.A., M.D. | Executive Officer | 59 |
| Dr. Thomas F. Frist Jr., M.D. | Founder & Chairman Emeritus | 86 |
| Mr. Christopher F. Wyatt | Senior VP, Principal Accounting Officer & Controller | 47 |
| Mr. Chad J. Wasserman | Senior VP & Chief Information Officer | - |
| Mr. Frank George Morgan C.F.A. | Vice President of Investor Relations | - |
| Ms. Wendy Warren | Senior VP and Chief Ethics & Compliance Officer | - |
Rischio Audit
8
Rischio CdA
9
Rischio Compensi
4
Rischio Diritti Azionisti
3
Parte 2 · Il prezzo e il momento d'ingresso
Questa parte non serve a capire se l'azienda vale: serve a scegliere quando comprarla, dopo che i fondamentali ti hanno convinto. Dentro: analisi tecnica, potenziale, drawdown storici, esposizione gamma.
Documenti
- Vedi documento
Relazione annuale (10-K)
Una panoramica annuale del business, dei risultati finanziari e dei rischi dell'azienda.
Depositato il 2026-02-10
- Vedi documento
Relazione trimestrale (10-Q)
Un aggiornamento sull'andamento finanziario degli ultimi tre mesi.
Depositato il 2026-07-28
- Vedi documento
Comunicazione price-sensitive (8-K)
Una comunicazione su un evento importante, come un cambio ai vertici o un grande annuncio.
Depositato il 2026-07-29
via SEC EDGAR
Storico Ricavi
via SEC EDGAR
Ultime Notizie
Ultime notizie per HCA, da Markets Gazette.
- 6/15/2026NEUTRALHere's How Much You Would Have Made Owning HCA Healthcare Stock In The Last 15 Years
An analysis of HCA Healthcare Inc. stock reveals its performance over the past 15 years. While the article title suggests a focus on potential returns for investors, the content itself is not provided, making it impossible to ascertain specific financial metrics, growth drivers, or any recent developments. Therefore, without detailed information on earnings, strategic initiatives, or market positioning, a definitive assessment of its current investment appeal or future outlook cannot be made. The historical performance, while potentially positive, does not offer actionable insights for present trading decisions.
- 4/24/2026NEUTRALHCA Healthcare Q1 2026 Earnings Call Transcript
HCA Healthcare is scheduled to hold its Q1 2026 Earnings Call on April 24, 2026. While the transcript is available, the provided information does not contain the actual earnings results, forward-looking guidance, or any specific operational updates that would allow for an assessment of financial performance or market impact. Investors should consult the full transcript or subsequent reports for detailed financial figures, management commentary on performance drivers, and future outlook.
- 4/24/2026POSITIVEHCA Healthcare Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
HCA Healthcare is poised to report its Q1 earnings on April 24th, with analysts projecting earnings per share of $7.15, a notable increase from $6.45 in the prior year. This upward revision in forecasts by analysts, who are recognized for their accuracy, suggests a positive outlook for the company's performance. The stock's modest 0.6% gain on Thursday further indicates investor optimism ahead of the earnings call. For investors, this anticipated earnings growth and analyst confidence signal potential for continued stock appreciation.
- 4/23/2026NEUTRALHow To Earn $500 A Month From HCA Healthcare Stock Ahead Of Q1 Earnings
HCA Healthcare offers an annual dividend yield of 0.66%, equating to $3.12 per share annually. The article explores strategies for investors to generate approximately $500 per month from this dividend, suggesting a focus on dividend reinvestment or accumulation strategies. While the dividend itself is a positive attribute for income-focused investors, the news primarily focuses on a strategy for income generation rather than a direct catalyst for stock price appreciation ahead of Q1 earnings. The actual Q1 earnings results, which are not yet released, will be the primary driver of short-term stock movement.
- 2/26/2026POSITIVEHere's How Much $1000 Invested In HCA Healthcare 15 Years Ago Would Be Worth Today
A retrospective analysis of an investment in HCA Healthcare reveals exceptional performance for long-term shareholders. An initial $1,000 investment made 15 years ago would today be worth a significantly larger sum, underscoring the robust and consistent growth of the healthcare sector and, specifically, this leading company. HCA Healthcare's ability to generate value over time, navigating economic cycles and market challenges, highlights its resilience and the strength of its business model. This data not only celebrates past success but also offers insights into the potential of strategic, long-term investments in defensive sectors and companies with solid fundamentals.
via Markets Gazette